BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spugnini E, Fais S. Proton pump inhibition and cancer therapeutics: A specific tumor targeting or it is a phenomenon secondary to a systemic buffering? Semin Cancer Biol 2017;43:111-8. [PMID: 28088584 DOI: 10.1016/j.semcancer.2017.01.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Foletti A, Fais S. Unexpected Discoveries Should Be Reconsidered in Science-A Look to the Past? Int J Mol Sci 2019;20:E3973. [PMID: 31443232 DOI: 10.3390/ijms20163973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Spugnini EP, Fais S. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors. Expert Opin Ther Pat 2020;30:15-25. [PMID: 31847622 DOI: 10.1080/13543776.2020.1704733] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
3 Harguindey S, Alfarouk K, Orozco JP, Hardonniere K, Stanciu D, Fais S, Devesa J. A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics. Int J Mol Sci 2020;21:E1110. [PMID: 32046158 DOI: 10.3390/ijms21031110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lu M, Xing H, Xun Z, Yang T, Zhao X, Cai C, Wang D, Ding P. Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems. European Journal of Pharmaceutical Sciences 2018;121:34-46. [DOI: 10.1016/j.ejps.2018.05.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
5 Gnocchi D, Del Coco L, Girelli CR, Castellaneta F, Cesari G, Sabbà C, Fanizzi FP, Mazzocca A. 1H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth. Sci Rep 2021;11:1259. [PMID: 33441568 DOI: 10.1038/s41598-020-78867-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Koltai T. Targeting the pH Paradigm at the Bedside: A Practical Approach. Int J Mol Sci 2020;21:E9221. [PMID: 33287221 DOI: 10.3390/ijms21239221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Spugnini EP, Logozzi M, Di Raimo R, Mizzoni D, Fais S. A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis. Int J Mol Sci. 2018;19. [PMID: 30544664 DOI: 10.3390/ijms19123968] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
8 Engin S, Barut EN, Barut B, Kadioglu Duman M, Kaya C, Kerimoglu G, Ozel A. Uroprotective effect of pantoprazole against cyclophosphamide-induced cystitis in mice. Support Care Cancer 2019;27:4273-81. [DOI: 10.1007/s00520-019-04731-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Johnsen KB, Gudbergsson JM, Andresen TL, Simonsen JB. What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019;1871:109-16. [DOI: 10.1016/j.bbcan.2018.11.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 19.0] [Reference Citation Analysis]
10 Estrada-Ortiz N, Lopez-Gonzales E, Woods B, Stürup S, de Graaf IAM, Groothuis GMM, Casini A. Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands. Toxicol Res (Camb) 2019;8:885-95. [PMID: 32190293 DOI: 10.1039/c9tx00149b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
11 Logozzi M, Mizzoni D, Di Raimo R, Andreotti M, Macchia D, Spada M, Fais S. In vivo antiaging effects of alkaline water supplementation. J Enzyme Inhib Med Chem. 2020;35:657-664. [PMID: 32106720 DOI: 10.1080/14756366.2020.1733547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Weston WW, Ganey T, Temple HT. The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics. BioDrugs 2019;33:137-58. [DOI: 10.1007/s40259-019-00338-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
13 Jin UH, Michelhaugh SK, Polin LA, Shrestha R, Mittal S, Safe S. Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth. Cancers (Basel) 2020;12:E2097. [PMID: 32731514 DOI: 10.3390/cancers12082097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Meng X, Xu Y, Lu Q, Sun L, An X, Zhang J, Chen J, Gao Y, Zhang Y, Ning X. Ultrasound-responsive alkaline nanorobots for the treatment of lactic acidosis-mediated doxorubicin resistance. Nanoscale 2020;12:13801-10. [DOI: 10.1039/d0nr03726e] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, Tuccitto A, Tagliabue E, Castelli C, Rivoltini L. Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol 2017;43:74-89. [PMID: 28267587 DOI: 10.1016/j.semcancer.2017.03.001] [Cited by in Crossref: 215] [Cited by in F6Publishing: 203] [Article Influence: 43.0] [Reference Citation Analysis]
16 Corbet C, Feron O. Tumour acidosis: from the passenger to the driver's seat. Nat Rev Cancer 2017;17:577-93. [DOI: 10.1038/nrc.2017.77] [Cited by in Crossref: 321] [Cited by in F6Publishing: 302] [Article Influence: 64.2] [Reference Citation Analysis]
17 Fliegel L. Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32776252 DOI: 10.1007/112_2020_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Liu J, Chen Q, Feng L, Liu Z. Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement. Nano Today 2018;21:55-73. [DOI: 10.1016/j.nantod.2018.06.008] [Cited by in Crossref: 123] [Cited by in F6Publishing: 88] [Article Influence: 30.8] [Reference Citation Analysis]
19 Halcrow PW, Geiger JD, Chen X. Overcoming Chemoresistance: Altering pH of Cellular Compartments by Chloroquine and Hydroxychloroquine. Front Cell Dev Biol 2021;9:627639. [PMID: 33634129 DOI: 10.3389/fcell.2021.627639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Jin UH, Karki K, Kim SB, Safe S. Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNK. Biochem Biophys Res Commun 2018;501:751-7. [PMID: 29758193 DOI: 10.1016/j.bbrc.2018.05.061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Cardone RA, Alfarouk KO, Elliott RL, Alqahtani SS, Ahmed SBM, Aljarbou AN, Greco MR, Cannone S, Reshkin SJ. The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela. Int J Mol Sci 2019;20:E3694. [PMID: 31357694 DOI: 10.3390/ijms20153694] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
22 Pérez-Herrero E, Fernández-Medarde A. The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers. Acta Pharm Sin B 2021;11:2243-64. [PMID: 34522586 DOI: 10.1016/j.apsb.2021.01.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
23 Logozzi M, Capasso C, Di Raimo R, Del Prete S, Mizzoni D, Falchi M, Supuran CT, Fais S. Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity. J Enzyme Inhib Med Chem 2019;34:272-8. [PMID: 30734594 DOI: 10.1080/14756366.2018.1538980] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
24 Logozzi M, Spugnini E, Mizzoni D, Di Raimo R, Fais S. Extracellular acidity and increased exosome release as key phenotypes of malignant tumors. Cancer Metastasis Rev 2019;38:93-101. [PMID: 30715644 DOI: 10.1007/s10555-019-09783-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
25 Gillies RJ, Pilot C, Marunaka Y, Fais S. Targeting acidity in cancer and diabetes. Biochim Biophys Acta Rev Cancer. 2019;1871:273-280. [PMID: 30708040 DOI: 10.1016/j.bbcan.2019.01.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
26 Liu C, Guo H, Mao H, Tong J, Yang M, Yan X. An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:753234. [PMID: 35280736 DOI: 10.3389/fonc.2022.753234] [Reference Citation Analysis]
27 Iessi E, Logozzi M, Mizzoni D, Di Raimo R, Supuran CT, Fais S. Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy. Metabolites 2017;8:E2. [PMID: 29295495 DOI: 10.3390/metabo8010002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
28 Bhattacharya S, Khanam J, Sarkar P, Pal TK. A chemotherapeutic approach targeting the acidic tumor microenvironment: combination of a proton pump inhibitor and paclitaxel for statistically optimized nanotherapeutics. RSC Adv 2019;9:240-54. [DOI: 10.1039/c8ra08924h] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Zhang M, Yu W, Zhou S, Zhang B, Lo ECM, Xu X, Zhang D. In vitro Antibacterial Activity of an FDA-Approved H+-ATPase Inhibitor, Bedaquiline, Against Streptococcus mutans in Acidic Milieus. Front Microbiol 2021;12:647611. [PMID: 33717046 DOI: 10.3389/fmicb.2021.647611] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Carraro U. Thirty years of translational research in Mobility Medicine: Collection of abstracts of the 2020 Padua Muscle Days. Eur J Transl Myol 2020;30:8826. [PMID: 32499887 DOI: 10.4081/ejtm.2019.8826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]